WELL Health Technologies (TSE:WELL) Price Target Raised to C$7.00

WELL Health Technologies (TSE:WELL - Free Report) had its target price upped by Scotiabank from C$6.00 to C$7.00 in a report issued on Monday morning,BayStreet.CA reports.

Several other research analysts have also recently issued reports on WELL. Haywood Securities increased their target price on shares of WELL Health Technologies from C$8.00 to C$10.00 in a report on Friday. CIBC lifted their price objective on shares of WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday. Finally, Ventum Financial lowered their target price on WELL Health Technologies from C$8.00 to C$7.00 and set a "buy" rating for the company in a report on Tuesday, October 29th.

WELL Health Technologies Trading Up 2.9 %

WELL traded up C$0.20 during trading on Monday, hitting C$6.99. 1,841,887 shares of the stock were exchanged, compared to its average volume of 888,206. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$7.05. The firm has a market cap of C$1.74 billion, a price-to-earnings ratio of 12.33, a P/E/G ratio of -1.93 and a beta of 1.20. The firm has a 50 day simple moving average of C$5.14 and a 200 day simple moving average of C$4.69. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.